These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28208861)

  • 21. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent plateletpheresis donations & its effect on haematological parameters: An observational study.
    Nayak S; Coshic P; Pandey RM; Chatterjee K
    Indian J Med Res; 2019 Nov; 150(5):468-476. PubMed ID: 31939390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant Platelets in Platelet Donors - A Blessing in Disguise?
    Roy AD; Choudhury N; Ray D
    J Clin Diagn Res; 2015 Jun; 9(6):EC01-3. PubMed ID: 26266124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron Store of Repeat Plasma and Platelet Apheresis Donors.
    Pfeiffer H; Hechler J; Zimmermann R; Hackstein H; Achenbach S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of initial values of donor platelets count on the efficiency of plateletpheresis with the cell separator Fenval Baxter Amicus s.v.2.51].
    Landzo E; Berbić-Fazlagić J; Sofo-Hafizović A
    Med Arh; 2009; 63(2):67-70. PubMed ID: 19537658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year.
    Rahmani M; Fortin BM; Berliner N; Issa N; Neuberg D; Kaufman RM; Gansner JM
    Transfusion; 2019 May; 59(5):1644-1647. PubMed ID: 30747442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Hematological Indices and Lymphocyte Subsets in Response to Platelet Apheresis Donation.
    Borai A; Bahijri S; Almohammadi M; Al-Sofyani A; Baljoon D; Al-Amri A; Boraie S; Ferns G
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowering the hemoglobin cutoff for female plateletpheresis donors.
    Fraser JL; Whatmough A; Uhl L; Kruskall MS
    Transfusion; 1998 Sep; 38(9):855-9. PubMed ID: 9738626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
    Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
    J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.
    Li H; Condon F; Kessler D; Nandi V; Rebosa M; Westerman M; Shaz BH; Ginzburg Y
    J Clin Apher; 2016 Dec; 31(6):551-558. PubMed ID: 26915437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
    Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
    Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of repeated platelet donation on megakaryopoiesis in donors].
    Dai YD; Sun QJ; Meng B; Xu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):320-2. PubMed ID: 15854301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.